Please login to the form below

Not currently logged in

Ex-Pfizer research head Dr David Roblin joins Destiny Pharma

The former head of research at Pfizer's European operations will be medical director at Destiny

Anti-microbial drug development company Destiny Pharma has appointed ex-Pfizer research head Dr David Roblin as medical director.

He headed up Pfizer's European research operations in Sandwich, Kent until March 2011 when he left following the company's announcement it would close the UK research site with the loss of 2,400 jobs.

Dr Roblin said: “After leaving Pfizer I wanted to work with smaller companies where I believe there is a good chance to bring important new medicines to patients and value to investors.

“I was attracted to the science coming out of Destiny. It is creating a class of antibiotics unique in its rapid activity and its efficacy on resistant organisms that are causing many problems in medical practice. This is a step change in antimicrobials and one I am very exciting about contributing to.”

He brings to Destiny 15 years' experience in senior R&D roles at Pfizer and Bayer and five years' experience of medical practice.

Dr Roblin will be joined at Destiny by Sir Nigel Rudd, the former head of BAA and ex-chief of Boots.

Based at the Sussex Innovation Centre near Brighton in the UK, Destiny focuses on anti-microbial drug development and its lead product, XF-73, targets antibiotic resistant strains of Staphylococcus aureus like MRSA.

7th November 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...